Custom anti-nausea treatment based on your genes
Part of Cancer, Skin clinical trials.
This trial tests if giving anti-nausea drugs based on your genetic makeup can better prevent vomiting and nausea from chemotherapy for early breast cancer. You will receive a personalized regimen tailored to your pharmacogenetic profile.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a Chinese woman between 18 and 74 years old.
- You have early breast cancer (not advanced) and have not had chemotherapy before.
- You are about to receive your first treatment with specific chemotherapy drugs (AC or FEC).
- You are not pregnant and agree to use birth control if premenopausal.
- You can read and fill out questionnaires and diaries.
- You do not have conditions like glaucoma, seizures, or Parkinson's disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of giving anti-nausea medication: one through an IV (drip) and one as a pill. Both are paired with a newer drug to prevent nausea and vomiting caused by chemotherapy in breast cancer patients.
This trial tests a new anti-nausea medicine combination for breast cancer patients getting AC chemotherapy, specifically designed for those with diabetes, obesity, or other metabolic issues. It aims to reduce the need for steroids, which can be riskier for these patients.
This study tests a new anti-nausea drug (HR20013) in patients receiving chemotherapy that often causes nausea and vomiting. It aims to see how well it works in real-world conditions, including for patients with liver problems.
This study tests whether electroacupuncture can help prevent nausea and vomiting caused by strong chemotherapy in people with breast cancer. If you're starting a certain type of chemo, this could help you feel better during treatment.
This trial tests whether adding electroacupuncture (a type of acupuncture with mild electrical pulses) to standard anti-nausea medicine can better prevent nausea and vomiting caused by strong chemotherapy. It is for people with early-stage breast cancer who are about to start a very strong chemotherapy regimen.
This trial tests a medication called LY3537021 to see if it can prevent nausea and vomiting caused by certain types of chemotherapy (AC or cisplatin) in people who have not had chemo before. It focuses on patients who are otherwise in fairly good health.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.